Phase Holographic Imaging PHI AB — Investor Relations & Filings

Phase Holographic Imaging (PHI) develops and provides instrumentation for non-invasive, label-free live cell analysis. The company's core technology is Quantitative Phase Imaging (QPI), a method based on digital holographic microscopy. Its primary product line, the HoloMonitor® system, consists of compact time-lapse cytometers designed for continuous operation directly inside a standard cell culture incubator. This approach enables researchers to monitor and quantify cell behavior over long periods in a stable, physiologically relevant environment without the use of potentially interfering labels or stains. The system automatically generates quantitative data on numerous cellular parameters, including morphology, proliferation, motility, and migration, for both single cells and cell populations. Key application areas include cancer research, drug development, and stem cell studies.